PCOS Is Now Called PMOS: What Every Woman in Gurgaon Needs to Know About This Major Change — By Dr. Chetna Jain

If you have been diagnosed with PCOS — Polycystic Ovary Syndrome — at any point in your life, you may have recently come across news that has been circulating widely across Indian health platforms and social media: PCOS has been officially renamed. The condition is now being referred to as PMOS — Polyendocrine Metabolic Ovarian Syndrome. And if you are wondering what this means for you, your diagnosis, your treatment, and your long-term health, you are in exactly the right place.

I am Dr. Chetna Jain, a senior gynaecologist in Gurgaon, and I have been following the evolution of this name change with great clinical interest — because it is not simply a rebrand. It reflects a fundamental shift in how the medical community understands and approaches this condition. In this blog I want to explain clearly what the change is, why it was made, what it means for women who already have a diagnosis, and why it matters enormously for the future of women's hormonal health care in India.

What Is PMOS — and Is It the Same Condition as PCOS?

Yes — PMOS and PCOS refer to the same underlying condition. The hormonal disorder that has affected hundreds of millions of women worldwide has not changed. What has changed is how we name it, how we describe it, and — crucially — how we are expected to investigate and manage it. PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. Let us break that down:

• Polyendocrine: The condition involves multiple endocrine (hormonal) systems — not just the ovaries. The hypothalamus, pituitary, adrenal glands, pancreas, and ovaries are all implicated. This is a full-body hormonal disorder.

• Metabolic: PMOS is fundamentally a metabolic condition. Insulin resistance — the body's impaired ability to respond to insulin — is present in the majority of women with PMOS and is now recognised as a central driver of the hormonal imbalance, not simply a side effect of weight gain.

• Ovarian Syndrome: The ovaries remain central to the clinical picture — irregular ovulation, androgen excess, and polycystic morphology are still diagnostic features — but the ovaries are now correctly framed as one system among several that are affected.

Why Was the Old Name 'PCOS' a Problem?

The original name — Polycystic Ovary Syndrome — was misleading in two significant ways that have caused real clinical harm to real women for decades.

Problem 1: Many Women With PCOS Never Had Ovarian Cysts

The word 'polycystic' implies the presence of cysts on the ovaries. But what we actually see on ultrasound in PCOS is not cysts — it is an increased number of small immature follicles, each smaller than a true cyst. Many women with all the hallmark features of PCOS — irregular periods, elevated testosterone, insulin resistance, hirsutism — have a completely normal-looking ovary on ultrasound. This caused enormous diagnostic confusion: women were told they did not have PCOS because their ultrasound was normal, when in fact the clinical diagnosis was clear. Equally, women were told they had PCOS based on ultrasound appearance alone, without the necessary hormonal and metabolic evaluation.

Problem 2: The Name Framed the Condition Entirely Around Reproduction

Calling it an 'ovarian syndrome' led generations of doctors — and patients — to think of it primarily as a fertility problem, or at most a hormonal issue affecting periods and ovulation. The profound metabolic dimensions of the condition were consistently underweighted or ignored. Women with PCOS have nearly 2.5 times the risk of heart attack and 1.7 times the risk of stroke compared to women without the condition. They have a four to seven times higher risk of developing Type 2 diabetes. Their risk of non-alcoholic fatty liver disease, endometrial cancer, obstructive sleep apnoea, and depression is significantly elevated. None of these risks are suggested by the phrase 'polycystic ovary syndrome' — and as a result, they were consistently missed in clinical practice.

I have seen this directly in my clinic in Gurgaon: women who were diagnosed with PCOS in their 20s, prescribed oral contraceptive pills to regulate their periods, and then left with no metabolic monitoring, no insulin assessment, and no long-term management plan — arriving in their late 30s and early 40s with prediabetes or dyslipidaemia that had been silently developing for a decade. The name led clinicians to treat the symptom — the period problem — and miss the systemic disease.

What Does the PMOS Rename Actually Change — Clinically?

The name change is not cosmetic. It carries real clinical implications for how the condition should be diagnosed, investigated, and managed.

1. Diagnosis Must Now Be Multisystem — Not Just Gynaecological

A diagnosis of PMOS formally requires assessment of multiple endocrine and metabolic systems alongside the gynaecological picture. An ultrasound and a hormonal panel are necessary but no longer sufficient. A complete PMOS workup at my clinic in Gurgaon includes the full hormonal panel — LH, FSH, testosterone, DHEA-S, prolactin, AMH — as before, but now explicitly combined with a comprehensive metabolic assessment — fasting insulin, fasting glucose, HbA1c, lipid profile — and a full thyroid panel. The condition cannot be properly diagnosed or managed without all of these.

2. Treatment Must Address Metabolic Health, Not Just Symptoms

The old approach — prescribing an oral contraceptive pill to regulate periods and sending the patient away — is no longer clinically adequate under the PMOS framework. Treatment must address insulin resistance as a central therapeutic target. This means lifestyle medicine — low-glycaemic index diet, regular exercise, weight management — is not optional: it is the primary treatment. Metformin, inositol, and other insulin-sensitising interventions are now more central to the management plan. Hormonal medications manage symptoms — but they do not treat the underlying metabolic disease. This has always been true. The new name makes it impossible to ignore.

3. Long-Term Monitoring Becomes a Clinical Obligation

Women with PMOS should now have annual monitoring of fasting glucose and HbA1c, lipid profiles, blood pressure, and cardiovascular risk factors — for life, not just during the reproductive years. The metabolic risks of PMOS do not disappear after menopause. In fact, the postmenopausal cardiovascular risk in women with PMOS is significantly elevated, and ongoing surveillance is essential for detecting and managing these risks early. This is a paradigm shift from the 'treat the period, discharge the patient' approach that has been standard in many Indian gynaecological practices.

4. Mental Health Is Now Formally Part of the PMOS Clinical Picture

Women with PMOS have significantly elevated rates of anxiety, depression, and body dysmorphia — driven by both the neurobiological effects of hormonal and metabolic dysregulation and the psychological burden of the condition's visible manifestations: the weight gain, the acne, the hair loss, the infertility. Under the PMOS framework, mental health screening and support are formally integrated into clinical management. A woman with PMOS who is struggling emotionally should not be offered only a prescription — she should be offered comprehensive care.

What Does NOT Change With the PMOS Rename

If you already have a PCOS diagnosis, here is what you need to know about what stays the same:

• The condition itself is identical. PMOS is not a new disease. It is PCOS with a more accurate name and a broader clinical framework.

• Your existing diagnosis is still valid. You do not need to be 'rediagnosed'. If you were diagnosed with PCOS under the Rotterdam Criteria, that diagnosis stands — you have PMOS.

• Core symptoms are unchanged. Irregular periods, androgen excess (acne, hirsutism, scalp hair loss), polycystic ovarian morphology on ultrasound, insulin resistance, and its metabolic consequences remain the defining features.

• Existing medications remain appropriate. Metformin, oral contraceptive pills, Letrozole for ovulation induction, anti-androgens — these are all still the correct therapeutic tools. The evidence supporting them has not changed.

• The condition remains manageable, not curable. PMOS, like PCOS, is a lifelong condition that is highly manageable with the right approach. The goal of treatment is symptom control, metabolic risk reduction, and quality of life — and those goals remain entirely achievable.

Why This Rename Matters Particularly for Women in India

India carries a disproportionate share of this condition's burden. Approximately 1 in 5 Indian women of reproductive age has PMOS — one of the highest prevalence rates in the world, driven by genetic susceptibility, dietary patterns, increasingly sedentary urban lifestyles, and near-universal Vitamin D deficiency in Indian cities. Yet the standard of care many Indian women receive for this condition falls dramatically short of what the condition requires.

Women in Gurgaon and across India are still being handed a pill prescription and sent home. They are still being told to simply lose weight. They are still not having their insulin levels measured, their lipid profiles checked, or their mental health assessed. They are still not being told that this condition carries meaningful cardiovascular and metabolic risk that requires lifelong monitoring. The PMOS rename — and the clinical framework it mandates — is an opportunity to change this. Whether clinicians in India rise to that opportunity is the question that will define women's hormonal health care in this country over the next decade.

What to Ask Your Doctor Now — If You Have a PCOS or PMOS Diagnosis

Whether you were diagnosed last month or ten years ago, here are the questions every woman with PMOS should be asking at her next gynaecological appointment:

• Has my insulin resistance been assessed? Has anyone measured my fasting insulin, fasting glucose, and HbA1c?

• Has my lipid profile been checked? Do I know my cardiovascular risk profile?

• Has my thyroid been evaluated — not just TSH but a full thyroid panel including anti-TPO antibodies?

• Is my treatment plan addressing my metabolic health — or only managing my period symptoms?

• What is my long-term monitoring plan? How often should I have blood tests to check for diabetes and cardiovascular risk?

• Has anyone asked me about my mental health, anxiety, or mood in the context of my PMOS?

If the answer to most of these questions is no — it is time for a more comprehensive PMOS review. I am here for that.

How I Am Applying the PMOS Framework at My Clinic in Gurgaon

I want to be transparent with my patients: the comprehensive approach that the PMOS framework now formally requires is the approach I have always taken — because the limitations of the old PCOS name never changed the biological reality of the condition. Insulin resistance, metabolic risk, mental health, and long-term cardiovascular surveillance have always been part of how I manage this condition at my clinic in Gurgaon.

What the PMOS rename does is validate this comprehensive approach at a global clinical standard level — and create the framework for other clinicians to be held to the same standard. For my patients, nothing changes in how I see them. For women in India who have been receiving inadequate PCOS care elsewhere, the PMOS name change creates a legitimate clinical basis for demanding better.

Frequently Asked Questions About PMOS

Q: Do I need to get rediagnosed now that it is called PMOS?

No — your existing PCOS diagnosis is entirely valid and automatically becomes a PMOS diagnosis. You do not need to start your diagnostic journey from scratch. However, if your original workup was limited — based only on ultrasound and a period history, without hormonal and metabolic blood tests — then yes, a comprehensive updated review is warranted to ensure all aspects of your PMOS are properly assessed and managed.

Q: I was told I have PCOS but no ovarian cysts. Does that mean I was misdiagnosed?

No — this is precisely one of the confusions the old name created. A PCOS diagnosis does not require ovarian cysts. Under the Rotterdam Criteria, you only need two of the three diagnostic features: irregular or absent ovulation, clinical or biochemical androgen excess, and polycystic ovarian morphology on ultrasound. Many women with a correct PCOS diagnosis have no visible cysts. The PMOS name resolves this confusion permanently — the condition is about polyendocrine and metabolic dysregulation, not cysts.

Q: Does PMOS affect women who are not trying to get pregnant?

Absolutely — and this is one of the most important messages of the PMOS rename. PMOS is not simply a fertility condition. It is a lifelong metabolic and hormonal disorder with significant cardiovascular, endocrine, dermatological, psychological, and oncological implications that are entirely independent of whether a woman is trying to conceive. Every woman with PMOS — whether she wants children or not, whether she is 22 or 52 — deserves comprehensive, ongoing clinical management.

Q: Will doctors in India start using the PMOS name?

The transition is already underway. Leading Indian medical institutions, the Indian Academy of Gynaecology, and major hospital networks have begun adopting the PMOS terminology. The change will take time to percolate through every clinic and every prescription pad — but the clinical framework it represents is the direction the field is moving. In the interim, whether your doctor uses the term PCOS or PMOS matters less than whether they are investigating and managing your condition comprehensively.

Book Your Comprehensive PMOS Review with Dr. Chetna Jain in Gurgaon

If you have a PCOS or PMOS diagnosis and your care has been limited to period management without metabolic assessment, long-term monitoring, or mental health support — please book a comprehensive review at my clinic in Gurgaon today. I serve women from Palam Vihar, DLF, South City, Sector 22, Sector 23, and all of NCR.

The name has changed. The woman with the condition has not. You are still the same person navigating the same very real challenges — and you deserve care that sees the full picture of what you are dealing with, not just the part that shows up on a period calendar.

PMOS is manageable. With the right care, it does not have to define your health — or your future.

— Dr. Chetna Jain | Senior Gynaecologist & PMOS Specialist | Gurgaon, Haryana